𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase II study of viscum fraxini-2 in patients with advanced hepatocellular carcinoma

✍ Scribed by Mabed, M; El-Helw, L; Shamaa, S

Book ID
120180397
Publisher
Nature Publishing Group
Year
2004
Tongue
English
Weight
144 KB
Volume
90
Category
Article
ISSN
0007-0920

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Phase 2 study of cetuximab in patients w
Phase 2 study of cetuximab in patients with advanced hepatocellular carcinoma
✍ Andrew X. Zhu; Keith Stuart; Lawrence S. Blaszkowsky; Alona Muzikansky; Donald P πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 131 KB πŸ‘ 1 views

## Abstract ## BACKGROUND. Epidermal growth factor receptor (EGFR) and ligand expression is frequently seen in hepatocellular carcinoma (HCC). A phase 2 study was performed with cetuximab, a chimeric monoclonal antibody that binds specifically to EGFR, in patients with advanced HCC. ## METHODS.